<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03853681</url>
  </required_header>
  <id_info>
    <org_study_id>PI-2019-02</org_study_id>
    <nct_id>NCT03853681</nct_id>
  </id_info>
  <brief_title>Study on the Response to Tetanus Vaccination of People Living With HIV</brief_title>
  <acronym>VACTEVIH</acronym>
  <official_title>Study on the Response to Tetanus Vaccination of People Living With HIV</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier de Niort</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier de Niort</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The response to primary tetanus immunization of HIV-infected children is lower than that of
      uninfected children.

      Response to tetanus toxoid (TT) booster doses in adults living with HIV who have received
      primary vaccination prior to infection is not known.

      Currently, it is recommended to have a TT booster for people living with HIV (PLHIV) every 10
      years. In general population, this recall is made only at 25, 45 and 65 years, then every 10
      years.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 11, 2019</start_date>
  <completion_date type="Anticipated">September 11, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 11, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the vaccine response to tetanus vaccination</measure>
    <time_frame>Month 6</time_frame>
    <description>An anti-tetanus IgG level&gt; 0.1 is considered long-term protective. An anti-tetanus IgG level between 0.01 and 0.1 is considered protective in the short term.
The measurement of the vaccine response will be correlated with the age of the last VAT recall (&lt;10 years, between 10 and 20 years,&gt; 20 years and unknown)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">172</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>additional blood sampling</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>additional blood sampling</intervention_name>
    <description>additional blood sampling</description>
    <arm_group_label>additional blood sampling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Person aged â‰¥ 18 years

          -  Person infected with HIV followed in the infectious diseases department of CH Niort

          -  Born in France

          -  Affiliate or beneficiary of a social security scheme

          -  Being able to give free and informed consent to participation in research

        Exclusion Criteria:

          -  Persons with a contraindication to tetanus vaccination

          -  Persons under guardianship or curatorship or without civil law
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simon SUNDER, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier de Niort - France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Simon SUNDER, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>CH Niort</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Simon SUNDER, Doctor</last_name>
    <phone>549 783 075</phone>
    <phone_ext>+33</phone_ext>
    <email>simon.sunder@ch-niort.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier de Niort</name>
      <address>
        <city>Niort</city>
        <zip>79000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SUNDER Simon, Doctor</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 15, 2019</study_first_submitted>
  <study_first_submitted_qc>February 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2019</study_first_posted>
  <last_update_submitted>March 25, 2019</last_update_submitted>
  <last_update_submitted_qc>March 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tetanus</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

